95% of Committee Members Advising on U.S. Dietary Guidelines Had Ties to Big Pharma, Big Food

Share this:

Describing their findings as “particularly worrisome,” the authors of a study published Monday in Public Health Nutrition noted that in the U.S., the Dietary Guidelines for Americans form “the foundation for all national nutrition programs,” which amount to nearly $100 billion annually.

A study released Monday found 95% — 19 of the 20 members — of the U.S. government-run committee responsible for establishing dietary guidelines for Americans have one or more conflicts of interest (COIs) with industry actors in Big Food, Big Ag and Big Pharma.

The U.S. Dietary Guidelines for Americans Advisory Committee (DGAC) sets the guidelines used by U.S. policymakers, healthcare providers, nutrition educators and federal nutrition program operators, including those responsible for school lunch programs, on what foods and beverages “meet nutrient needs, promote health and prevent disease.”

According to the study, 129 industry actors had relationships with the 20 DGAC members, based on the COI disclosures submitted by the members of the committee.

Describing their findings as “particularly worrisome,” the authors of the study explained why this is a matter of public concern, noting that in the U.S., the Dietary Guidelines for Americans form “the foundation for all national nutrition programs,” which amount to nearly $100 billion annually.

The DGA also offers guidance to state and local governments, as well as healthcare professionals, hospitals, and community groups, among others, as “overarching dietary recommendations.”

The study’s authors added:

“Trustworthy dietary guidelines result from a transparent, objective, and science-based, process. Our analysis has shown that the significant and widespread COI on the committee prevent the DGA from achieving the recommended standard for transparency without mechanisms in place to make this information publicly available.

“Our findings here are particularly worrisome, as industry influence and COI can result in diverting the scientific process underpinning the U.S. national dietary guidelines, to one that is responsive to profit-driven interests rather than the public health.”

The study appeared in Public Health Nutrition, published by Cambridge University Press on behalf of The Nutrition Society, a UK-based nonprofit whose mission is to advance the scientific study of nutrition.

The DGAC, first convened in 1977, operates under the U.S. Department of Agriculture (USDA) and the U.S. Department of Health and Human Services (HHS). The report, since its introduction in 1980, is revised and re-released every five years.

The DGAC’s latest report, issued in July 2020, led to the publication in December 2020 of the ninth version of the Dietary Guidelines for Americans.

Did committee members influence policy on breastmilk substitutes to promote product sales?

In an example of the depth and extent of the conflicts of interest identified, the authors of the study highlighted examples such as the following, involving food and nutritional products produced for infants and young children:

“[T]he Pregnancy and Lactation Subcommittee of the DGAC had six members, four of whom, or two thirds, had COI involving manufacturers of breastmilk substitutes: SD, RK, KD, JS [referring to DGAC committee members] all had instances of COI with Mead Johnson, and SD had COI with Wyeth and Abbot [sic].

“The Birth to Age 24 Months Subcommittee, which also addressed infant and young child nutrition, had four of its six members having COI involving manufacturers of breastmilk substitutes: SD, RK, KD also served on the Pregnancy and Lactation Subcommittee, with the same COI mentioned above; and TD had at least one COI with Abbott.

“There is evidence that those companies producing breastmilk substitutes regularly use science and try to influence policy in order to protect and promote the sales of their products, and their relationships with DGAC members may have had a direct impact on the work of those members.”

The study also highlighted the following findings:

“Our analysis found that 95% of the committee members had COI [conflicts of interest] with the food, and/or pharmaceutical industries and that particular actors, including Kellogg, Abbott, Kraft, Mead Johnson, General Mills, Dannon, and the International Life Sciences [Institute or ILSI] had connections with multiple members.

“Research funding and membership of an advisory/executive board jointly accounted for more than 60% of the total number of COI documented.

“We observed the existence of extensive, varied and long-standing relationships between some DGAC members and industry actors whose products are directly affected by the DGAC report ́s recommendations as well as the DGA themselves.

“[W]e can observe that Kellogg, Abbott, Kraft, Mead Johnson, ILSI, General Mills and Dannon are well-positioned to advance their interests within the DGAC given the existence of relationships (in some cases long-held) with several DGAC members.

“The most prevalent type of COI was research funding, followed by DGAC members being on a board/committee in a company, and consultant positions. Some industry actors, such as Mead Johnson, General Mills and Kellogg’s and the industry-funded organization, ILSI, have interacted with an extensive number of DGAC members.

“Conversely, other industry actors have prolonged relationships with only a handful of DGAC members. Amongst the top 15 industry actors by overall number of COI are ILSI and three trade associations or programs funded by them (California Walnut Commission, Almond Board of California and Beef Checkoff). Each of these actors has diverse means and ends to potentially influence scientific research and the DGA process.”

How ‘revolving door’ policies come into play…

Continue reading the full story [icon name=”arrow-right” prefix=”fas”] 95% of Committee Members Advising on U.S. Dietary Guidelines Had Ties to Big Pharma, Big Food • Children’s Health Defense


Share this:
Scroll to Top